Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V. & Fendt, S.-M. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev. Cell 56, 1363–1393 (2021).
Riscal, R. et al. Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma. Cancer Discov. 11, 3106–3125 (2021).
Garcia-Bermudez, J. et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature 567, 118–122 (2019).
Zhang, M. et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discov. 8, 1006–1025 (2018).
Villa, G. R. et al. An LXR-cholesterol axis creates a metabolic co-dependency for brain cancers. Cancer Cell 30, 683–693 (2016).
Medes, G., Thomas, A. & Weinhouse, S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 13, 27–29 (1953).
Mashima, T., Seimiya, H. & Tsuruo, T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer 100, 1369–1372 (2009).
Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012).
Lang, X. et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 9, 1673–1685 (2019).
Ubellacker, J. M. et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature 585, 113–118 (2020).
Freitas, F. P. et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature 626, 401–410 (2024).
Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688–692 (2019).
Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317–331 (2014).
Cai, Y. et al. Vitamin D suppresses ferroptosis and protects against neonatal hypoxic-ischemic encephalopathy by activating the Nrf2/HO-1 pathway. Transl. Pediatr. 11, 1633–1644 (2022).
Traber, M. G. & Atkinson, J. Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 43, 4–15 (2007).
Mishima, E. et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 608, 778–783 (2022).
Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693–698 (2019).
Magtanong, L. et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem. Biol. 26, 420–432 (2019).
Quehenberger, O. & Dennis, E. A. The human plasma lipidome. N. Engl. J. Med. 365, 1812–1823 (2011).
Hoofnagle, A. N. & Heinecke, J. W. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J. Lipid Res. 50, 1967–1975 (2009).
Shah, R., Farmer, L. A., Zilka, O., Van Kessel, A. T. M. & Pratt, D. A. Beyond DPPH: use of fluorescence-enabled inhibited autoxidation to predict oxidative cell death rescue. Cell Chem. Biol. 26, 1594–1607 (2019).
Ou, W. et al. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma. Free Radic. Biol. Med. 112, 597–607 (2017).
Behrens, W. A. & Madère, R. Alpha- and gamma tocopherol concentrations in human serum. J. Am. Coll. Nutr. 5, 91–96 (1986).
Traber, M. G. & Arai, H. Molecular mechanisms of vitamin E transport. Annu. Rev. Nutr. 19, 343–355 (1999).
Spickett, C. M. The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis. Redox Biol. 1, 145–152 (2013).
Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540–551 (2015).
Ito, J. et al. PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization. Mol. Cell 84, 4629–4644 (2024).
Matsuda, M. et al. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 15, 1206–1216 (2001).
Pomin, V. H. & Mulloy, B. Glycosaminoglycans and proteoglycans. Pharmaceuticals 11, 27 (2018).
Sasisekharan, R., Shriver, Z., Venkataraman, G. & Narayanasami, U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2, 521–528 (2002).
Asimakopoulou, A. P., Theocharis, A. D., Tzanakakis, G. N. & Karamanos, N. K. The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. In Vivo 22, 385–389 (2008).
Yang, W. S. & Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234–245 (2008).
Volpi, N. & Tarugi, P. Influence of chondroitin sulfate charge density, sulfate group position, and molecular mass on Cu2+-mediated oxidation of human low-density lipoproteins: effect of normal human plasma-derived chondroitin sulfate. J. Biochem. 125, 297–304 (1999).
Koppula, P., Zhang, Y., Shi, J., Li, W. & Gan, B. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. J. Biol. Chem. 292, 14240–14249 (2017).
Flood, C. et al. Identification of the proteoglycan binding site in apolipoprotein B48. J. Biol. Chem. 277, 32228–32233 (2002).
Goldstein, J. L., Basu, S. K., Brunschede, G. Y. & Brown, M. S. Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans. Cell 7, 85–95 (1976).
Whereat, A. F. & Staple, E. The preparation of serum lipoproteins labeled with radioactive cholesterol. Arch. Biochem. Biophys. 90, 224–228 (1960).
Klaassen, C. D. & Boles, J. W. Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11, 404–418 (1997).
Kearns, A. E., Campbell, S. C., Westley, J. & Schwartz, N. B. Initiation of chondroitin sulfate biosynthesis: a kinetic analysis of UDP-d-xylose: core protein β-d-xylosyltransferase. Biochemistry 30, 7477–7483 (1991).
Piskounova, E. et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527, 186–191 (2015).
Zilka, O. et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent. Sci. 3, 232–243 (2017).
Brown, M. S., Kovanen, P. T. & Goldstein, J. L. Regulation of plasma cholesterol by lipoprotein receptors. Science 212, 628–635 (1981).
Pownall, H. J., Rosales, C., Gillard, B. K. & Gotto, A. M. High-density lipoproteins, reverse cholesterol transport and atherogenesis. Nat. Rev. Cardiol. 18, 712–723 (2021).
Li, Z. et al. Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability. Nat. Chem. Biol. 18, 751–761 (2022).
Kurokawa, S., Bellinger, F. P., Hill, K. E., Burk, R. F. & Berry, M. J. Isoform-specific binding of selenoprotein P to the β-propeller domain of apolipoprotein E receptor 2 mediates selenium supply. J. Biol. Chem. 289, 9195–9207 (2014).
Basu, A., Patel, N. G., Nicholson, E. D. & Weiss, R. J. Spatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease. Am. J. Physiol. Cell Physiol. 322, C849–C864 (2022).
Wight, T. N. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 14, 617–623 (2002).
Nandadasa, S. et al. The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors. Matrix Biol. 97, 40–57 (2021).
Noborn, F. et al. Site-specific identification of heparan and chondroitin sulfate glycosaminoglycans in hybrid proteoglycans. Sci. Rep. 6, 34537 (2016).
Varki, A. Biological roles of glycans. Glycobiology 27, 3–49 (2017).
Harris, F. M., Best, K. B. & Bell, J. D. Use of laurdan fluorescence intensity and polarization to distinguish between changes in membrane fluidity and phospholipid order. Biochim. Biophys. Acta 1565, 123–128 (2002).
Liu, D., Shriver, Z., Venkataraman, G., El Shabrawi, Y. & Sasisekharan, R. Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl Acad. Sci. USA 99, 568–573 (2002).
Prinz, R. D., Willis, C. M., Viloria-Petit, A. & Klüppel, M. Elimination of breast tumor-associated chondroitin sulfate promotes metastasis. Genet. Mol. Res. 10, 3901–3913 (2011).
Qi, X., Li, Q., Che, X., Wang, Q. & Wu, G. The uniqueness of clear cell renal cell carcinoma: summary of the process and abnormality of glucose metabolism and lipid metabolism in ccRCC. Front. Oncol. 11, 727778 (2021).
Gatto, F. et al. Glycosaminoglycan profiling in patients’ plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinoma. Cell Rep. 15, 1822–1836 (2016).
Evanko, S. P. et al. A role for HAPLN1 during phenotypic modulation of human lung fibroblasts in vitro. J. Histochem. Cytochem. 68, 797–811 (2020).
Elias, R. et al. A renal cell carcinoma tumorgraft platform to advance precision medicine. Cell Rep. 37, 110055 (2021).
Klein, E. A. et al. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306, 1549–1556 (2011).
MacArthur, J. M. et al. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J. Clin. Invest. 117, 153–164 (2007).
Hurt, E., Bondjers, G. & Camejo, G. Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J. Lipid Res. 31, 443–454 (1990).
Brandes, C. et al. Alternative splicing in the ligand binding domain of mouse ApoE receptor-2 produces receptor variants binding reelin but not α2-macroglobulin. J. Biol. Chem. 276, 22160–22169 (2001).
Garcia-Bermudez, J. et al. Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia. Nat. Metab. 4, 724–738 (2022).
Guo, L. S., Hamilton, R. L., Goerke, J., Weinstein, J. N. & Havel, R. J. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21, 993–1003 (1980).
Giera, M. et al. XCMS-METLIN: data-driven metabolite, lipid, and chemical analysis. Mol. Syst. Biol. 20, 1153–1155 (2024).
Xue, J., Guijas, C., Benton, H. P., Warth, B. & Siuzdak, G. METLIN MS2 molecular standards database: a broad chemical and biological resource. Nat. Methods 17, 953–954 (2020).
De Leenheer, A. P., De Bevere, V. O., Cruyl, A. A. & Claeys, A. E. Determination of serum alpha-tocopherol (vitamin E) by high-performance liquid chromatography. Clin. Chem. 24, 585–590 (1978).
Mathieu, R. E. & Riley, C. P. Quantitation of ubiquinone (coenzyme Q10) in serum/plasma using liquid chromatography electrospray tandem mass spectrometry (ESI-LC-MS/MS). Methods Mol. Biol. 1378, 61–69 (2016).
Basu, A. et al. Quantitative HILIC-Q-TOF-MS analysis of glycosaminoglycans and non-reducing end carbohydrate biomarkers via glycan reductive isotopic labeling. Preprint at ChemRxiv (2025).
Basu, A. & Weiss, R. J. Glycosaminoglycan analysis: purification, structural profiling, and GAG-protein interactions. Methods Mol. Biol. 2597, 159–176 (2023).
Li, L. et al. A mouse model with high clonal barcode diversity for joint lineage, transcriptomic, and epigenomic profiling in single cells. Cell 186, 5183–5199 (2023).
Bezwada, D. et al. Mitochondrial complex I promotes kidney cancer metastasis. Nature 633, 923–931 (2024).
Pavía-Jiménez, A., Tcheuyap, V. T. & Brugarolas, J. Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing. Nat. Protoc. 9, 1848–1859 (2014).
Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593–598 (2008).
Watanabe, Y., Aoki-Kinoshita, K. F., Ishihama, Y. & Okuda, S. GlycoPOST realizes FAIR principles for glycomics mass spectrometry data. Nucleic Acids Res. 49, D1523–D1528 (2021).
